Clinical Trial VICCTHO0398
Title
Molecular Predictors of Lung Cancer Behavior. (SPORE)
Principal Investigator(s)
Details
- Protocol No. VICCTHO0398
- Open Date: 12/04/2003
- Staging: NA
- Age Group: Adults
- Scope: Local
- Objective:
- Disease Sites:
- Therapies: Correlative
- Drugs: None Specified
- Participating Institutions: Veterans Administration; Vanderbilt University
- National Clinical Trial ID: NCT00898313
- Secondary Protocol No: VICCTHO0398
Description
None Provided.
Eligibility
| Ages Eligible for Study: | 18 Years and older |
|---|---|
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
-All adults referred to Vanderbilt Medical Center, Veterans Administration Medical Center, St. Thomas Hospital and Meharry Medical Center for evaluation of signs or symptoms of lung cancer.
Exclusion Criteria:
• Inability to provide informed consent
• Minors
• Pregnant women
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
